Invention Grant
US09549942B2 Composition for preventing or treating degenerative brain diseases including compound downregulating expression of BACE1 proteins
有权
用于预防或治疗退行性脑疾病的组合物,包括下调BACE1蛋白表达的化合物
- Patent Title: Composition for preventing or treating degenerative brain diseases including compound downregulating expression of BACE1 proteins
- Patent Title (中): 用于预防或治疗退行性脑疾病的组合物,包括下调BACE1蛋白表达的化合物
-
Application No.: US14330583Application Date: 2014-07-14
-
Publication No.: US09549942B2Publication Date: 2017-01-24
- Inventor: Dong Gyu Jo , Jong Sung Park , Youngkwang Youn , Yuri Choi , Ui Jeong Yun
- Applicant: RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY
- Applicant Address: KR Suwon-si
- Assignee: Research & Business Foundation Sungkyunkwan University
- Current Assignee: Research & Business Foundation Sungkyunkwan University
- Current Assignee Address: KR Suwon-si
- Priority: KR10-2013-0083098 20130715; KR10-2014-0069137 20140609
- Main IPC: A01N43/04
- IPC: A01N43/04 ; A61K31/70 ; A61K31/7076 ; A61K31/155 ; A61K31/045 ; A61K31/165 ; A61K31/4184 ; A61K31/706 ; A61K31/7068 ; A61K31/708 ; A61K31/7064

Abstract:
The present disclosure relates to a pharmaceutical composition, a health functional food composition, and a method for preventing or treating a brain disease or diabetes. The pharmaceutical composition, health functional food composition, and method includes at least one active ingredient that is chlorhexidine, thioguanosine, mebendazole, fenbendazole, colchicine, farnesol, trimethobenzamide hydrochloride, disulfuram, azathioprine, mebeverine hydrochloride, zaprinast, tosufloxacin hydrochloride, efavirenz, thiostrepton, probenecid, entacapone, harmine hydrochloride, flunisolide, thimerosal, hexestrol, sulfaquinoxaline sodium salt, monensin sodium salt, raloxifene hydrochloride, 2-chloropyrazine, or topotecan.
Public/Granted literature
Information query
IPC分类: